A Safety and Pharmacokinetics Study of ZB004 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

March 21, 2024

Study Completion Date

March 21, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

ZB004

ZB004 single doses administered subcutaneously as solution

DRUG

Placebo

Placebo single doses administered subcutaneously as solution

Trial Locations (1)

NZCR New Zealand Clinical Research, Christchurch

All Listed Sponsors

lead

Zenas BioPharma (USA), LLC

INDUSTRY